Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Kimberly-Clark (NYSE:KMB - Get Rating) had its target price decreased by stock analysts at Deutsche Bank Aktiengesellschaft from $134.00 to $117.00 in a research note issued on Friday, The Fly reports. Deutsche Bank Aktiengesellschaft's target price would suggest a potential upside of 2.11% from the stock's previous close.
Several other analysts have also recently commented on the company. UBS Group raised their target price on Kimberly-Clark from $136.00 to $142.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 27th. Atlantic Securities raised Kimberly-Clark from a "neutral" rating to an "overweight" rating and set a $135.00 target price on the stock in a research note on Wednesday. Morgan Stanley reduced their price target on shares of Kimberly-Clark from $137.00 to $132.00 and set an "equal weight" rating for the company in a research report on Tuesday, October 4th. Bank of America began coverage on shares of Kimberly-Clark in a research report on Wednesday, September 14th. They set a "neutral" rating on the stock. Finally, StockNews.com assumed coverage on shares of Kimberly-Clark in a research note on Wednesday. They set a "buy" rating for the company. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $128.79.Kimberly-Clark Trading Up 1.5 %
Shares of NYSE KMB opened at $114.58 on Friday. The business has a fifty day simple moving average of $125.01 and a 200-day simple moving average of $129.48. The company has a market cap of $38.68 billion, a price-to-earnings ratio of 21.66, a P/E/G ratio of 3.86 and a beta of 0.37. Kimberly-Clark has a 12 month low of $108.74 and a 12 month high of $145.79. The company has a quick ratio of 0.47, a current ratio of 0.79 and a debt-to-equity ratio of 10.37.
Kimberly-Clark (NYSE:KMB - Get Rating) last announced its earnings results on Tuesday, July 26th. The company reported $1.34 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.01). The firm had revenue of $5.06 billion during the quarter, compared to analyst estimates of $4.99 billion. Kimberly-Clark had a return on equity of 249.60% and a net margin of 8.87%. The business's quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.47 earnings per share. Sell-side analysts predict that Kimberly-Clark will post 5.62 EPS for the current year. Institutional Investors Weigh In On Kimberly-Clark
Several hedge funds and other institutional investors have recently made changes to their positions in the business. New Millennium Group LLC acquired a new stake in Kimberly-Clark in the 2nd quarter valued at approximately $27,000. Wagner Wealth Management LLC acquired a new stake in shares of Kimberly-Clark in the second quarter worth $28,000. Roble Belko & Company Inc increased its position in Kimberly-Clark by 69.5% during the first quarter. Roble Belko & Company Inc now owns 256 shares of the company's stock worth $32,000 after acquiring an additional 105 shares during the period. West Oak Capital LLC boosted its holdings in Kimberly-Clark by 50.0% in the 2nd quarter. West Oak Capital LLC now owns 240 shares of the company's stock valued at $32,000 after purchasing an additional 80 shares during the period. Finally, DeDora Capital Inc. acquired a new stake in Kimberly-Clark in the 1st quarter worth $33,000. 74.36% of the stock is owned by institutional investors and hedge funds. Kimberly-Clark Company Profile (Get Rating)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names.Read MoreGet a free copy of the StockNews.com research report on Kimberly-Clark (KMB)Trinseo Gets A Downgrade But That Doesn't Stop It From AdvancingDelta Air Lines Looks Ready To Take OffDoes the Zillow Stock Forecast Hint Toward a Turnaround?The Rally in Walgreen’s Boots Alliance May be Short LivedWill MGM Resorts Rise to the Top of the Casino Food Chain?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Brian Mulberry brings three large-cap ideas today and discusses why one utility may have potential beyond the traditional role of a dividend payer
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.